TAmiRNA GmbH

At TAmiRNA we drive innovation through microRNA and RNAi technology to solve unmet clinical needs.

[TAmiRNA GmbH @rna_ami]

Take advantage, meet Matthias Hackl at at #ISSXDMDG2023 this June 11-14, and discuss our latest developments and how #TAmiRNA’s miND spike ins and services can assist your business! https://t.co/GKL9Rf4eqU

[TAmiRNA GmbH @rna_ami]

We are thrilled about the opportunity to present our miND® spike-in at the 28th Annual International Conference RNA 2023 in Singapore next week https://t.co/nFkhURcONy

[TAmiRNA GmbH @rna_ami]

TAmiRNA is awarded ISO 13485:2016 certification of its Quality Management System
#TAmiRNA #microRNA #Biotech https://t.co/VqMuOM7o2Z

[TAmiRNA GmbH @rna_ami]

TAmiRNA is searching for a new team member. You are looking for a new Job feel free to apply!
https://t.co/LKfuyEa7Bh

[TAmiRNA GmbH @rna_ami]

Update: TAmiRNA presents mind for absolute quantitation of NGS data to the EV community at ISEV meeting in Lyon https://t.co/gXWav5NgBG #TAmiRNA #microRNA #Biotech

[TAmiRNA GmbH @rna_ami]

Update: TAmiRNA partners with BioCat to open up new international markets https://t.co/ch9UXljjLj #TAmiRNA #microRNA #Biotech

[TAmiRNA GmbH @rna_ami]

TAmiRNA is searching for a new team member. You are looking for a new Job feel free to apply! #TAmiRNA #microRNA #Biotech #jobopportunities
https://t.co/nP4JaylHEF

[TAmiRNA GmbH @rna_ami]

Update: TAmiRNA to present a novel assay for for Genome-Scale Analysis and Absolute Quantitation of MicroRNAs across Sample Types and Species at RNA Biology Microsymposium https://t.co/TvDfJ7mG6C #TAmiRNA #microRNA #Biotech

[TAmiRNA GmbH @rna_ami]

Update: TAmiRNA offers hepatomiR® RUO RT-qPCR test kit for novel liver function biomarkers https://t.co/jjoMzaAyKd #TAmiRNA #microRNA #Biotech

[TAmiRNA GmbH @rna_ami]

Update: New study confirms useful detection limits for TAmiRNA SARS-CoV-2 rapid antibody test https://t.co/onEJM541xK #TAmiRNA #microRNA #Biotech

[TAmiRNA GmbH @rna_ami]

Update: TAmiRNA offers one-stop-shop characterization of extracellular vesicles https://t.co/L3LOM0VWYy #TAmiRNA #microRNA #Biotech

[TAmiRNA GmbH @rna_ami]

Longevity senotherapeutics report: TAmiRNA https://t.co/OmkNQS8Oj1 via @LongevityTech

[Longevity Technology @LongevityTech]

'@rna_ami was founded to explore the use of #microRNAs as osteoporosis biomarkers (osteomiR®) and subsequently also #CVD, liver disease and #senescence.'

https://t.co/qqyQQOfVNF

#senolytics #biotech #biotechnology #biotechinvestors

[Longevity Technology @LongevityTech]

We interviewed Dr @aubreydegrey founder and Chief Science Officer of @senstweet and member of our Advisory Panel, who provided the foreword to our #senotherapeutics report.

https://t.co/tA96cmYgkG

#senolytics #biotech #biotechnology #biotechinvestors

[Longevity Technology @LongevityTech]

Our #senotherapeutics report briefing video is now online. Featuring:

Atropos Therapeutics; @ClearaBiotech; @InSilicoMeds; Oisin Biotechnologies; @RockfishBio; Rubedo Life Sciences; and @rna_ami.

https://t.co/Os5o80EKe0

#senolytics #biotech #biotechnology #biotechinvestors

[FIDELIO-ITN @FIDELIO_ITN]

Our colleague Matthias Hackl of TAmiRNA @rna_ami in Austria is giving @ECTS_soc webinar May 27th 1600 CEST on Circulating non-coding RNAs as #biomarkers for #bone metabolism https://t.co/i26MIoE6bt

[FIDELIO-ITN @FIDELIO_ITN]

Our FIDELIO webinar "An introduction to #microRNAs" with Matthias Hackl from TAmiRNA GmbH @rna_ami now available at our YouTube channel https://t.co/LiOgofLPCI

[TAmiRNA GmbH @rna_ami]

One year COVID-19 pandemic - see what we have been up to in this last year. - https://t.co/otASwCajTd

[FIDELIO-ITN @FIDELIO_ITN]

Next FIDELIO webinar features Peter Vestergaard from STENO Diabetes Center North Denmark on "Treatment of #diabetic #bone disease – the bone, the sugar or both?" Thursday 23rd March, 1400 CET, OPEN TO ALL please register via https://t.co/EdbbIyez3Q